| Title : Pharmacological and toxicological in vitro and in vivo effect of higher doses of oxime reactivators - Hepnarova_2019_Toxicol.Appl.Pharmacol__114776 |
| Author(s) : Hepnarova V , Muckova L , Ring A , Pejchal J , Herman D , Misik J , Hrabinova M , Jun D , Soukup O |
| Ref : Toxicol Appl Pharmacol , :114776 , 2019 |
| PubMedID: 31629733 |
| Title : Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods - Janockova_2018_Molecules_23_ |
| Author(s) : Janockova J , Dolezal R , Nepovimova E , Kobrlova T , Benkova M , Kuca K , Konecny J , Mezeiova E , Melikova M , Hepnarova V , Ring A , Soukup O , Korabecny J |
| Ref : Molecules , 23 : , 2018 |
| PubMedID: 30423961 |
| Title : Bispyridinium Compounds Inhibit Both Muscle and Neuronal Nicotinic Acetylcholine Receptors in Human Cell Lines - Ring_2015_PLoS.One_10_e0135811 |
| Author(s) : Ring A , Strom BO , Turner SR , Timperley CM , Bird M , Green AC , Chad JE , Worek F , Tattersall JE |
| Ref : PLoS ONE , 10 :e0135811 , 2015 |
| PubMedID: 26274808 |
| Title : Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects - Graefe-Mody_2011_Drug.Metab.Pharmacokinet_26_123 |
| Author(s) : Graefe-Mody U , Rose P , Ring A , Zander K , Iovino M , Woerle HJ |
| Ref : Drug Metab Pharmacokinet , 26 :123 , 2011 |
| PubMedID: 21084763 |
| Title : Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects - Retlich_2010_Clin.Pharmacokinet_49_829 |
| Author(s) : Retlich S , Duval V , Ring A , Staab A , Huttner S , Jungnik A , Jaehde U , Dugi KA , Graefe-Mody U |
| Ref : Clinical Pharmacokinetics , 49 :829 , 2010 |
| PubMedID: 21053992 |
| Title : Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes - Forst_2010_Diabet.Med_27_1409 |
| Author(s) : Forst T , Uhlig-Laske B , Ring A , Graefe-Mody U , Friedrich C , Herbach K , Woerle HJ , Dugi KA |
| Ref : Diabet Med , 27 :1409 , 2010 |
| PubMedID: 21059094 |
| Title : Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase-4 inhibitor linagliptin and pioglitazone in healthy volunteers - Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652 |
| Author(s) : Graefe-Mody EU , Jungnik A , Ring A , Woerle HJ , Dugi KA |
| Ref : Int J Clinical Pharmacology & Therapeutics , 48 :652 , 2010 |
| PubMedID: 20875371 |
| Title : Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients - Heise_2009_Diabetes.Obes.Metab_11_786 |
| Author(s) : Heise T , Graefe-Mody EU , Huttner S , Ring A , Trommeshauser D , Dugi KA |
| Ref : Diabetes Obes Metab , 11 :786 , 2009 |
| PubMedID: 19476474 |